GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Applied Molecular Transport Inc (NAS:AMTI) » Definitions » Median PS Value

Applied Molecular Transport (Applied Molecular Transport) Median PS Value : $0.00 (As of May. 05, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Applied Molecular Transport Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Applied Molecular Transport's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0. Applied Molecular Transport's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is $0.00.

As of today (2024-05-05), Applied Molecular Transport's share price is $0.263. Applied Molecular Transport's Median PS Value is $0.00. Therefore, Applied Molecular Transport's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Applied Molecular Transport's Median PS Value or its related term are showing as below:

AMTI's Price-to-Median-PS-Value is not ranked *
in the Biotechnology industry.
Industry Median: 0.68
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Applied Molecular Transport Median PS Value Historical Data

The historical data trend for Applied Molecular Transport's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied Molecular Transport Median PS Value Chart

Applied Molecular Transport Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Median PS Value
- - - - -

Applied Molecular Transport Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Applied Molecular Transport's Median PS Value

For the Biotechnology subindustry, Applied Molecular Transport's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied Molecular Transport's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Applied Molecular Transport's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Applied Molecular Transport's Price-to-Median-PS-Value falls into.



Applied Molecular Transport Median PS Value Calculation

Applied Molecular Transport's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0*
=0.00

10-Year Median PS Ratio is .
Applied Molecular Transport's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied Molecular Transport  (NAS:AMTI) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Applied Molecular Transport's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.263/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied Molecular Transport Median PS Value Related Terms

Thank you for viewing the detailed overview of Applied Molecular Transport's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied Molecular Transport (Applied Molecular Transport) Business Description

Traded in Other Exchanges
N/A
Address
450 East Jamie Court, South San Francisco, CA, USA, 94080
Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.
Executives
Shawn Cross officer: Chief Financial Officer 1825 K STREET SUITE 510, WASHINGTON DC 20006
Mahmood Tahir Ph.d. director, officer: Chief Executive Officer 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Brandon Hants officer: VP, Finance & Bus. Ops. 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Douglas A. Rich officer: Chief Technical Officer C/O KYTHERA BIOPHARMACEUTICALS, INC., 30930 RUSSELL RANCH ROAD, 3RD FLOOR, WESTLAKE VILLAGE CA 91362
Bittoo Kanwar officer: Chief Medical Officer 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Mrsny Randall Ph.d. director, officer: Chief Scientific Officer 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Aaron Vandevender director 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
David Lamond director C/O CORTEXYME, INC., 269 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080
Epiq Capital Group, Llc other: Managing member of 10% owner ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111
Chad Boeding other: CEO of Managing Member ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111
Charlene A. Banard director C/O APPLIED MOLECULAR TRANSPORT INC., 450 EAST JAMIE COURT, SOUTH SAN FRANCISCO CA 94080
John W Smither director C/O KYTHERA BIOPHARMACEUTICALS, INC., 27200 WEST AGOURA ROAD, SUITE 200, CALABASAS CA 91301
Epq Llc Amt Ps other: Owner 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521
Epq Llc, Amtc Ps other: Owner 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521
Epq Llc, Amtb Ps 10 percent owner 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521